US FDA approves over-the-counter Tylenol combination pill for pain relief
The FDA has officially cleared the first over-the-counter combination tablet containing both acetaminophen and naproxen sodium for pain relief.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
The US Food and Drug Administration has authorized a fixed-dose combination tablet containing 650 mg of acetaminophen and 220 mg of naproxen sodium. This product is approved for use by individuals aged 12 and older for up to 12 hours of pain relief.
Coverage from Reuters, USA Today, Kenvue, Consultant360, and Contemporary Pediatrics emphasizes that this is the first time these two commonly used pain medications have been combined into a single over-the-counter pill. Reporting highlights the regulatory milestone for the dual-action formula.
Future updates will focus on the availability of the product in retail markets and subsequent consumer guidance regarding the transition to a combination dosage. Specific distribution timelines have not been established.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated just now.
Quick answers
Who is eligible to take the new combination pill?
The FDA has approved the medication for individuals aged 12 and older.
What is the dosage of the active ingredients?
The tablet contains 650 mg of acetaminophen and 220 mg of naproxen sodium.
How long does the pain relief last?
Coverage states the pill is intended to provide up to 12 hours of pain relief.
Coverage (5)
- FDA approves acetaminophen-naproxen sodium combination tablet for ages 12 and older Contemporary Pediatrics · 2h ago
- FDA Approves First OTC Acetaminophen–Naproxen Combination for Up to 12 Hours of Pain Relief Consultant360 · 2h ago
- FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) Kenvue · 2h ago
- Two pain drugs used by millions will be combined in a single tablet USA Today · 2h ago
- US FDA approves over-the-counter Tylenol combination pill for pain relief Reuters · 2h ago
Topics
Related trends
Sanofi abandons plan to seek approval for eczema drug from $1.1B Kymab buyout
Sanofi is scrapping trials for an eczema drug derived from its billion-dollar acquisition of Kymab following a pipeline review.
Trump Live Updates: FDA Peptide Meetings, Tariffs and Latest News
FDA advisory panels are currently debating the regulatory path and clinical viability of peptides following efforts to increase access to the controversial drugs.
An FDA Panel Just Endorsed These Unproven Peptides
An FDA advisory panel has voted to permit the use of unproven peptides, sparking a conflict with agency scientists.
U.S. health officials investigate new outbreak of parasite cyclospora
U.S. health officials are investigating a widespread outbreak of the diarrhea-causing parasite cyclospora across nine states.
FDA advisory committee votes to add popular peptide BPC-157 to drug compounding list
An FDA advisory committee has voted to add the popular peptide BPC-157 to the drug compounding list despite agency opposition.
Eli Lilly’s Anticipated Weight Loss Drug Helped People Lose 56 Pounds On Average
Eli Lilly is moving toward FDA approval for its weight loss drug retatrutide following successful Phase 3 trial results.